David Cipolla

3.3k total citations
84 papers, 2.5k citations indexed

About

David Cipolla is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Physiology. According to data from OpenAlex, David Cipolla has authored 84 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 18 papers in Pharmaceutical Science and 14 papers in Physiology. Recurrent topics in David Cipolla's work include Inhalation and Respiratory Drug Delivery (36 papers), Cystic Fibrosis Research Advances (23 papers) and Advanced Drug Delivery Systems (14 papers). David Cipolla is often cited by papers focused on Inhalation and Respiratory Drug Delivery (36 papers), Cystic Fibrosis Research Advances (23 papers) and Advanced Drug Delivery Systems (14 papers). David Cipolla collaborates with scholars based in Australia, United States and United Kingdom. David Cipolla's co-authors include Igor Gonda, Hak‐Kim Chan, Jim Blanchard, Ben J. Boyd, Boris Y. Shekunov, Thomas Rades, Anthony J. Hickey, Qi Zhou, Heejun Park and Nivedita Shetty and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

David Cipolla

77 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Cipolla Australia 29 1.5k 735 534 341 308 84 2.5k
Heidi M. Mansour United States 36 2.1k 1.4× 1.0k 1.4× 569 1.1× 454 1.3× 460 1.5× 123 3.7k
Francesca Buttini Italy 29 1.5k 1.0× 1.2k 1.6× 384 0.7× 277 0.8× 298 1.0× 97 2.7k
Rahul Kumar Verma India 26 726 0.5× 627 0.9× 365 0.7× 361 1.1× 368 1.2× 92 2.3k
Jason T. McConville United States 29 1.0k 0.7× 1.4k 1.9× 350 0.7× 220 0.6× 228 0.7× 55 2.3k
Philip Chi Lip Kwok Australia 32 1.3k 0.9× 666 0.9× 415 0.8× 212 0.6× 515 1.7× 87 2.7k
Rita Vanbever Belgium 38 2.1k 1.5× 1.7k 2.4× 732 1.4× 218 0.6× 572 1.9× 87 4.2k
Sharon Shui Yee Leung Hong Kong 35 793 0.5× 416 0.6× 761 1.4× 210 0.6× 680 2.2× 84 3.0k
Abdelbary Elhissi United Kingdom 28 887 0.6× 859 1.2× 700 1.3× 568 1.7× 615 2.0× 74 2.5k
Imran Saleem United Kingdom 28 563 0.4× 612 0.8× 424 0.8× 354 1.0× 253 0.8× 67 1.8k
Agnese Miro Italy 28 869 0.6× 1.1k 1.4× 542 1.0× 487 1.4× 403 1.3× 67 2.5k

Countries citing papers authored by David Cipolla

Since Specialization
Citations

This map shows the geographic impact of David Cipolla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cipolla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cipolla more than expected).

Fields of papers citing papers by David Cipolla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cipolla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cipolla. The network helps show where David Cipolla may publish in the future.

Co-authorship network of co-authors of David Cipolla

This figure shows the co-authorship network connecting the top 25 collaborators of David Cipolla. A scholar is included among the top collaborators of David Cipolla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cipolla. David Cipolla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corboz, Michel R., et al.. (2024). Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 37(5). 241–283. 1 indexed citations
2.
Nguyen, Tam L., Christina C. Chang, David Cipolla, et al.. (2024). Treprostinil palmitil inhalation powder leverages endogenous lung enzymes to provide sustained treprostinil. Expert Opinion on Drug Delivery. 21(8). 1297–1305. 1 indexed citations
3.
Baker, Thomas, Zhili Li, Vladimir Malinin, et al.. (2022). Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder. SHILAP Revista de lepidopterología. 2. 4 indexed citations
4.
Zhang, Jimin, et al.. (2022). An optimized method of extracting and quantifying active Neutrophil serine proteases from human whole blood cells. PLoS ONE. 17(8). e0272575–e0272575. 7 indexed citations
5.
Anderson, Sandra D., Paul J. Atkins, Per Bäckman, et al.. (2022). Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews. 74(1). 48–118. 79 indexed citations
6.
Chow, Michael Y.T., et al.. (2021). Modeling of a spray drying method to produce ciprofloxacin nanocrystals inside the liposomes utilizing a response surface methodology: Box-Behnken experimental design. International Journal of Pharmaceutics. 597. 120277–120277. 41 indexed citations
7.
Corboz, Michel R., Adam J. Plaunt, Vladimir Malinin, et al.. (2021). Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension. European Journal of Pharmacology. 916. 174484–174484. 7 indexed citations
8.
Li, Zhili, Walter R. Perkins, & David Cipolla. (2021). Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology. European Journal of Pharmaceutics and Biopharmaceutics. 166. 10–18. 32 indexed citations
9.
Cipolla, David, et al.. (2020). Reflections on Digital Health Tools for Respiratory Applications. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(3). 127–132. 5 indexed citations
10.
Chalmers, James D., David Cipolla, Bruce Thompson, et al.. (2020). Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies. European Respiratory Journal. 56(4). 2000110–2000110. 35 indexed citations
11.
Nowell, Cameron J., et al.. (2019). Direct Comparison of Standard Transmission Electron Microscopy and Cryogenic-TEM in Imaging Nanocrystals Inside Liposomes. Molecular Pharmaceutics. 16(4). 1775–1781. 38 indexed citations
12.
Tang, Li, Andrew J. Clulow, Cameron J. Nowell, et al.. (2019). Controlling the size and shape of liposomal ciprofloxacin nanocrystals by varying the lipid bilayer composition and drug to lipid ratio. Journal of Colloid and Interface Science. 555. 361–372. 11 indexed citations
13.
Tang, Li, David Cipolla, Thomas Rades, & Ben J. Boyd. (2018). Drug nanocrystallisation within liposomes. Journal of Controlled Release. 288. 96–110. 111 indexed citations
14.
Li, Tang, Stephen Mudie, David Cipolla, Thomas Rades, & Ben J. Boyd. (2018). Solid State Characterization of Ciprofloxacin Liposome Nanocrystals. Molecular Pharmaceutics. 16(1). 184–194. 14 indexed citations
15.
Roche, Nicolás, G. Scheuch, J.N. Pritchard, et al.. (2016). Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(1). 1–13. 26 indexed citations
16.
17.
Serisier, David J., et al.. (2010). Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans. Queensland's institutional digital repository (The University of Queensland). 354–354. 3 indexed citations
18.
Weers, Jeffry G., John Bell, Hak‐Kim Chan, et al.. (2010). Pulmonary Formulations: What Remains to be Done?. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(S2). S–5. 91 indexed citations
19.
Agosti, Jan M., et al.. (2001). Aerosolized Protein Delivery in Asthma: Gamma Camera Analysis of Regional Deposition and Perfusion. Journal of Aerosol Medicine. 14(2). 185–195. 41 indexed citations
20.
Jones, LaToya S., David Cipolla, Jun Liu, Steven J. Shire, & Theodore W. Randolph. (1999). Investigation of Protein-Surfactant Interactions by Analytical Ultracentrifugation and Electron Paramagnetic Resonance: The Use of Recombinant Human Tissue Factor as an Example. Pharmaceutical Research. 16(6). 808–812. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi M. Mansour Breakdown of academic impact, for papers by Francesca Buttini Breakdown of academic impact, for papers by Rahul Kumar Verma Breakdown of academic impact, for papers by Jason T. McConville Breakdown of academic impact, for papers by Philip Chi Lip Kwok Breakdown of academic impact, for papers by Rita Vanbever Breakdown of academic impact, for papers by Sharon Shui Yee Leung Breakdown of academic impact, for papers by Abdelbary Elhissi Breakdown of academic impact, for papers by Imran Saleem Breakdown of academic impact, for papers by Agnese Miro
Rankless by CCL
2026